NCT04137835 Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
| NCT ID | NCT04137835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Osteoarthritis, Hip |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2021-06-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2021-06-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is very important to understand joint and body kinematics and muscles activity in clinical settings, which is relevant to identify issues related to the spine, the upper and lower limbs due to injury. In this study, the investigators will use an innovative platform, Showmotion to establish baseline of shoulder, hip, knee and spine kinematics and muscles activity from 60 healthy volunteers.
Eligibility Criteria
Inclusion Criteria: * Healthy people (without musculoskeletal pathologies of the joint of interest) * Age \> 18, \<65 * Volunteers given written informed consent * Ability to understand and execute instructions at all stages of the procedure Exclusion Criteria: * Age \> 65, \< 18 * Active infections * Surgery at joint of interest * BMI (Body Mass Index) \>30 kg/m2 * Pregnancy
Contact & Investigator
Vikas Patel, MD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT04137835 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Osteoarthritis, Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04137835 currently recruiting?
Yes, NCT04137835 is actively recruiting participants. Contact the research team at CLAIRE.COFER@CUANSCHUTZ.EDU for enrollment information.
Where is the NCT04137835 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT04137835 clinical trial?
NCT04137835 is sponsored by University of Colorado, Denver. The principal investigator is Vikas Patel, MD at University of Colorado, Denver. The trial plans to enroll 60 participants.